• About Us
  • Team
  • News
  • Contact
  • About Us
  • Team
  • News
  • Contact

Archives

Author Archive for: "PPLAdmin"
Home » Archives for PPLAdmin
0
By PPLAdmin
In News
Posted January 19, 2021

Cardurion Pharmaceuticals Announces Appointment of Howard K. Surks, M.D., as Chief Scientific Officer and Head, Translational Medicine

READ MORE
0
By PPLAdmin
In News
Posted July 9, 2020

Cardurion Pharmaceuticals Announces Appointment of Chris Morabito, M.D., as Chief Medical Officer

READ MORE
2
By PPLAdmin
In News
Posted April 22, 2020

Cardurion Pharmaceuticals Announces Appointment of Peter Lawrence as President and Chief Executive Officer

April 15, 2020 07:30 AM Eastern Daylight Time BOSTON – (BUSINESS WIRE) – Cardurion Pharmaceuticals, Inc. (Cardurion), a Boston-based, clinical-stage biotechnology company focused on discovering [...]

READ MORE
0
By PPLAdmin
In News
Posted November 20, 2019

Cardurion Pharmaceuticals Announces Investment from Polaris Partners and Appoints Amy Schulman to Board of Directors

BOSTON, Mass. – November 20, 2019 – Cardurion Pharmaceuticals, a biotechnology company focused on the development of novel, next-generation therapeutics for the treatment of heart failure and [...]

READ MORE
0
By PPLAdmin
In News
Posted November 12, 2018

Cardurion Pharmaceuticals Presents Preclinical Data for CRD-733 at the American Heart Association Scientific Sessions and Announces Initiation of Phase 1b Study in Patients with Heart Failure
CRD-733 treatment reduced or reversed several markers of heart failure and reversed pressure overload-induced cardiac hypertrophy in animal models

November 12, 2018 09:00 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cardurion Pharmaceuticals, a biotechnology company focused on the development of novel, [...]

READ MORE
Navigation
  • About Us
  • Team
  • News
  • Contact
Contact Us

Cardurion Pharmaceuticals
Email: info@cardurion.com

Proudly Built By

Bellwether Digital